Guidelines for morpholino use in zebrafish.
Stainier DYR, Raz E, Lawson ND, Ekker SC, Burdine RD, Eisen JS, Ingham PW, Schulte-Merker S, Yelon D, Weinstein BM, Mullins MC, Wilson SW, Ramakrishnan L, Amacher SL, Neuhauss SCF, Meng A, Mochizuki N, Panula P, Moens CB. · 2017
Read Guidelines for morpholino use in zebrafish. by Stainier DYR, Raz E, Lawson ND, Ekker SC, Burdine RD, Eisen JS, Ingham PW, Schulte-Merker S, Yelon D, Weinstein BM, Mullins MC, Wilson SW, Ramakrishnan L, Amacher SL, Neuhauss SCF, Meng A, Mochizuki N, Panula P, Moens CB. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5648102.txt.
Description
Stainier and co-authors present updated guidelines in PLoS Genetics. The subject is morpholino use in zebrafish research. Morpholinos are short synthetic molecules injected into embryos. They bind target RNA and block gene function. The tool became popular before easy genome editing existed. Mutant lines from CRISPR and other tools now abound.
Comparisons revealed a problem with the older results. Morpholino effects often run stronger than mutant effects. Causes may include off-target action or genetic compensation in mutants. Maternal RNA rescue can also differ between the two. The guidelines urge using morpholinos beside matching mutants. Direct comparison should come before any new phenotype claim. Reviewers get advice for judging such studies fairly.
Catalog record
| CREATOR | Stainier DYR, Raz E, Lawson ND, Ekker SC, Burdine RD, Eisen JS, Ingham PW, Schulte-Merker S, Yelon D, Weinstein BM, Mullins MC, Wilson SW, Ramakrishnan L, Amacher SL, Neuhauss SCF, Meng A, Mochizuki N, Panula P, Moens CB. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 13 KB |
| LICENSE | CC0 1.0 Universal |
| RIGHTS | CC0 |
| SOURCE | Europe PMC |